Cargando…
A Standardized Antiviral Pipeline for Human Norovirus in Human Intestinal Enteroids Demonstrates No Antiviral Activity of Nitazoxanide
Human noroviruses (HuNoVs) are the leading cause of acute gastroenteritis. In immunocompetent hosts, symptoms usually resolve within three days; however, in immunocompromised persons, HuNoV infection can become persistent, debilitating, and sometimes life-threatening. There are no licensed therapeut...
Autores principales: | Lewis, Miranda A., Cortés-Penfield, Nicolás W., Ettayebi, Khalil, Patil, Ketki, Kaur, Gurpreet, Neill, Frederick H., Atmar, Robert L., Ramani, Sasirekha, Estes, Mary K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245936/ https://www.ncbi.nlm.nih.gov/pubmed/37293103 http://dx.doi.org/10.1101/2023.05.23.542011 |
Ejemplares similares
-
2650. Evaluating Antiviral Agents for Human Noroviruses Using a Human Intestinal Enteroid Model
por: Cortes-Penfield, Nicolas W, et al.
Publicado: (2019) -
New Insights and Enhanced Human Norovirus Cultivation in Human Intestinal Enteroids
por: Ettayebi, Khalil, et al.
Publicado: (2021) -
Norovirus Protease Structure and Antivirals Development
por: Zhao, Boyang, et al.
Publicado: (2021) -
Genetic Manipulation of Human Intestinal Enteroids Demonstrates the Necessity of a Functional Fucosyltransferase 2 Gene for Secretor-Dependent Human Norovirus Infection
por: Haga, Kei, et al.
Publicado: (2020) -
Human Norovirus Cultivation in Nontransformed Stem Cell-Derived Human Intestinal Enteroid Cultures: Success and Challenges
por: Estes, Mary K., et al.
Publicado: (2019)